SG47725A1 - Combination pediatric vaccine with enhanced immunogenicity of each vaccine component - Google Patents

Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Info

Publication number: SG47725A1
Authority: SG; Singapore
Prior art keywords: vaccine; enhanced immunogenicity; component; combined; pediatric
Prior art date: 1992-10-27

Application number

SG1996004072A

Other languages

English (en)

Inventor

Peter R Paradiso

Deborah A Hogerman

Dace Viceps Madore

Jill G Hackell

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-27

Filing date

1993-07-22

Publication date

1998-04-17

1993-07-22 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1998-04-17 Publication of SG47725A1 publication Critical patent/SG47725A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Mycology (AREA)
Microbiology (AREA)
Immunology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Inorganic Compounds Of Heavy Metals (AREA)
Peptides Or Proteins (AREA)

SG1996004072A 1992-10-27 1993-07-22 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component SG47725A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US96699592A	1992-10-27	1992-10-27

Publications (1)

Publication Number	Publication Date
SG47725A1 true SG47725A1 (en)	1998-04-17

Family

ID=25512167

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1996004072A SG47725A1 (en)	1992-10-27	1993-07-22	Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Country Status (22)

Country	Link
EP (1)	EP0594950B1 (ru)
JP (1)	JPH07300427A (ru)
KR (1)	KR100289224B1 (ru)
AT (1)	ATE176157T1 (ru)
AU (1)	AU669570B2 (ru)
CA (1)	CA2109159A1 (ru)
CZ (1)	CZ283587B6 (ru)
DE (2)	DE69323264D1 (ru)
DK (1)	DK0594950T3 (ru)
ES (1)	ES2126616T3 (ru)
FI (1)	FI934725L (ru)
GR (1)	GR3029884T3 (ru)
HU (1)	HU215149B (ru)
IL (1)	IL107387A (ru)
LV (1)	LV12271B (ru)
NO (1)	NO308588B1 (ru)
NZ (1)	NZ250029A (ru)
PL (1)	PL174130B1 (ru)
RU (1)	RU2121365C1 (ru)
SG (1)	SG47725A1 (ru)
TW (1)	TW256774B (ru)
UA (1)	UA27754C2 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995024216A1 (en) *	1994-03-07	1995-09-14	Auckland Uniservices Limited	Prevention of diabetes
WO1996040242A1 (en) *	1995-06-07	1996-12-19	Smithkline Beecham Biologicals S.A.	Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
US20020054884A1 (en)	1995-06-23	2002-05-09	Smithkline Beecham Biologicals, Sa	Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
CN1146444C (zh) *	1995-06-23	2004-04-21	史密斯克莱·比奇曼生物公司	含有吸附于磷酸铝上的多糖偶联抗原的疫苗组合物
TR199802783T2 (xx) *	1996-07-02	1999-03-22	Connaught Laboratories Limited	�ok de�erli DTP polyo a��lar.
GB0108364D0 (en) *	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
CZ20024224A3 (cs) *	2000-06-29	2003-05-14	Glaxosmithkline Biologicals S. A.	Farmaceutický prostředek
RU2175557C1 (ru) *	2000-09-04	2001-11-10	Волков Александр Григорьевич	Способ предупреждения воспалительных заболеваний верхних дыхательных путей
WO2003009869A1 (en) *	2001-07-26	2003-02-06	Chiron Srl.	Vaccines comprising aluminium adjuvants and histidine
HUE034801T2 (en)	2002-11-01	2018-02-28	Glaxosmithkline Biologicals Sa	Drying procedure
RU2231793C1 (ru) *	2003-03-11	2004-06-27	Москаленко Екатерина Петровна	Способ оценки иммуногенности коклюшных вакцин
RU2244548C1 (ru) *	2003-07-17	2005-01-20	Оренбургская государственная медицинская академия (ОГМА)	Средство, повышающее иммуногенные свойства столбнячного анатоксина
RU2274474C1 (ru) *	2004-10-12	2006-04-20	Государственное образовательное учреждение ВПО Красноярская государственная медицинская академия Министерства здравоохранения РФ	Способ вакцинации детей против краснухи на крайнем севере
GB0505996D0 (en) *	2005-03-23	2005-04-27	Glaxosmithkline Biolog Sa	Fermentation process
PL2878307T3 (pl)	2005-06-27	2020-01-31	Glaxosmithkline Biologicals S.A.	Kompozycja immunogenna
RU2303459C1 (ru) *	2005-12-05	2007-07-27	ГУ научно-исследовательский институт медицинских проблем Севера СО РАМН (РФ)	Способ вакцинации детей против краснухи на крайнем севере
RU2299744C1 (ru) *	2006-03-02	2007-05-27	ГОУ ВПО "Красноярская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию"	Способ сезонной ревакцинации детей против краснухи на крайнем севере

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ188211A (en) *	1977-10-28	1984-09-28	American Cyanamid Co	Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
US4673574A (en) *	1981-08-31	1987-06-16	Anderson Porter W	Immunogenic conjugates
US4902506A (en) *	1983-07-05	1990-02-20	The University Of Rochester	Immunogenic conjugates
CA1209036A (en) *	1982-08-20	1986-08-05	Joseph S.C. Kuo	Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
HU188847B (en) *	1983-02-22	1986-05-28	Human Oltoanyagtermeloe Es Kutato Intezet,Hu	Process for producing liophylized combined vaccines
US4761283A (en) *	1983-07-05	1988-08-02	The University Of Rochester	Immunogenic conjugates
DK163176C (da) *	1985-09-27	1992-06-22	Schweiz Serum & Impfinst	Ugiftig konjugatvaccine mod infektioner af pseudomonas aeruginosa- og escherichia coli- bakterier, fremgangsmaade til fremstilling heraf og anvendelse af vaccinen

1993
- 1993-07-22 DK DK93111735T patent/DK0594950T3/da active
- 1993-07-22 EP EP93111735A patent/EP0594950B1/en not_active Expired - Lifetime
- 1993-07-22 SG SG1996004072A patent/SG47725A1/en unknown
- 1993-07-22 DE DE69323264A patent/DE69323264D1/de not_active Expired - Fee Related
- 1993-07-22 ES ES93111735T patent/ES2126616T3/es not_active Expired - Lifetime
- 1993-07-22 AT AT93111735T patent/ATE176157T1/de not_active IP Right Cessation
- 1993-07-22 DE DE69323264T patent/DE69323264T4/de not_active Expired - Lifetime
- 1993-08-10 TW TW082106371A patent/TW256774B/zh active
- 1993-10-21 JP JP5285570A patent/JPH07300427A/ja active Pending
- 1993-10-22 NZ NZ250029A patent/NZ250029A/en unknown
- 1993-10-22 RU RU93048161A patent/RU2121365C1/ru active
- 1993-10-25 CA CA002109159A patent/CA2109159A1/en not_active Abandoned
- 1993-10-25 IL IL107387A patent/IL107387A/xx not_active IP Right Cessation
- 1993-10-26 PL PL93300859A patent/PL174130B1/pl unknown
- 1993-10-26 FI FI934725A patent/FI934725L/fi unknown
- 1993-10-26 AU AU50290/93A patent/AU669570B2/en not_active Ceased
- 1993-10-26 KR KR1019930022374A patent/KR100289224B1/ko not_active Expired - Fee Related
- 1993-10-26 HU HU9303028A patent/HU215149B/hu not_active IP Right Cessation
- 1993-10-26 CZ CZ932272A patent/CZ283587B6/cs not_active IP Right Cessation
- 1993-10-26 NO NO933856A patent/NO308588B1/no not_active IP Right Cessation
- 1993-10-27 UA UA93003281A patent/UA27754C2/ru unknown
1999
- 1999-02-22 LV LVP-99-29A patent/LV12271B/en unknown
- 1999-04-05 GR GR990400973T patent/GR3029884T3/el unknown

Also Published As

Publication number	Publication date
DE69323264D1 (de)	1999-03-11
GR3029884T3 (en)	1999-07-30
HK1009931A1 (en)	1999-06-11
NZ250029A (en)	1994-09-27
EP0594950A1 (en)	1994-05-04
UA27754C2 (ru)	2000-10-16
JPH07300427A (ja)	1995-11-14
NO308588B1 (no)	2000-10-02
KR100289224B1 (ko)	2001-05-02
CZ283587B6 (cs)	1998-05-13
ATE176157T1 (de)	1999-02-15
PL174130B1 (pl)	1998-06-30
AU5029093A (en)	1994-05-12
LV12271B (en)	1999-07-20
FI934725A7 (fi)	1994-04-28
DE69323264T4 (de)	1999-10-14
FI934725A0 (fi)	1993-10-26
NO933856L (no)	1994-04-28
DK0594950T3 (da)	1999-09-13
HU9303028D0 (en)	1994-01-28
HU215149B (hu)	2000-03-28
KR940008698A (ko)	1994-05-16
LV12271A (lv)	1999-05-20
IL107387A (en)	1997-04-15
NO933856D0 (no)	1993-10-26
EP0594950B1 (en)	1999-01-27
HUT67239A (en)	1995-03-28
ES2126616T3 (es)	1999-04-01
DE69323264T2 (de)	1999-06-02
AU669570B2 (en)	1996-06-13
RU2121365C1 (ru)	1998-11-10
CA2109159A1 (en)	1994-04-28
TW256774B (ru)	1995-09-11
FI934725L (fi)	1994-04-28
CZ227293A3 (en)	1994-05-18
IL107387A0 (en)	1994-01-25

Publication	Publication Date	Title
HUT67239A (en)	1995-03-28	Combination pediatric vaccine with enhanced immunogenicity of each vaccine component
AU696338B2 (en)	1998-09-10	A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
BR9710460A (pt)	1999-08-17	Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
CA2198251A1 (en)	1996-02-29	Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
SI1296715T1 (sl)	2012-03-30	Multivalentni sestavek cepiva
HU913103D0 (en)	1992-01-28	Method for producing vaccines of oligosacharide conjugates
IL119962A (en)	2000-01-31	Process for making a pneumococcal polysaccharide - immunogenic protein conjugate
WO1989006974A3 (en)	1989-08-24	T-cell epitope as carriers molecule for conjugate vaccines
RU93048161A (ru)	1996-09-27	Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
WO1997035613A1 (en)	1997-10-02	Method of producing immunogenic products and vaccines
Audibert et al.	1984	Of antigens, adjuvants, and carriers in synthetic vaccines.
Egorkov et al.	1990	Immunological activity of small doses of diphtheria and tetanus toxoids in booster immunization of children with allergically altered responsiveness and adults.
Guo et al.	1987	Studies on meningococcal polysaccharide-tetanus toxoid conjugates.